Atlas Trials

Akcea Therapeutics

15 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Akcea Therapeutics

RecordFirmDate
TEGSEDI Pregnancy Surveillance Program (NCT04270058)Akcea Therapeutics2025-12-01
A Non-interventional Cohort Safety Study of Patients With hATTR-PN (NCT04850105)Akcea Therapeutics2021-09-21
A Study to Characterize Adverse Events Occurring Within One Day of TEGSEDI Administration to Adult Participants With hATTR-PN (NCT04306510)Akcea Therapeutics2021-01-21
Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL) (NCT03514420)Akcea Therapeutics2018-06-15
Study of AKCEA-ANGPTL3-LRX (ISIS 703802) in Patients With Homozygous Familial Hypercholesterolemia (HoFH) (NCT03455777)Akcea Therapeutics2018-04-12
Study of ISIS 681257 in Patients With Renal Impairment Compared to Healthy Patients (NCT03506854)Akcea Therapeutics2018-03-20
Study of ISIS 678354 (AKCEA-APOCIII-LRx) in Participants With Hypertriglyceridemia and Established Cardiovascular Disease (CVD) (NCT03385239)Akcea Therapeutics2018-01-30
Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Clopidogrel (NCT03392051)Akcea Therapeutics2017-12-28
Phase 2 Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Chylomicronemia Syndrome (FCS) (NCT03360747)Akcea Therapeutics2017-12-21
Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease (NCT03371355)Akcea Therapeutics2017-12-21
Drug-drug Interaction Study to Evaluate the Effect of ISIS 681257 on Warfarin (NCT03426033)Akcea Therapeutics2017-12-15

Track Akcea Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.